And apparently this group of researchers and associated University are applying for a patent that would use Leronlimab with a specific salt (two separate treatments) to treat brain injury and a few other injuries associated with the spinal cord...

Inventors
Roslyn Mary Bill
West Midlands (GB)
Stuart David Greenhill
West Midlands (GB)
Luke David Southan
West Midlands (GB)

Applicants
ASTON UNIVERSITY
West Midlands (GB)

Application #
18/277,718

Confirmation #
2679

Attorney Docket #
11497-009US1

Patent #
-

Filing or 371 (c) date
08/17/2023

Status
Docketed New Case - Ready for Examination 01/31/2024

Well, at the very least, once approved we would have at least two indications that would put Leronlimab in high demand. I don't understand the implications should this group win a patent. Anyone understand the impact this patent approval would have?